ArticleEuropean journal of pharmacology2023

Synergism of small molecules targeting VDAC with sorafenib, regorafenib or lenvatinib on hepatocarcinoma cell proliferation and survival.

C Ventura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.